StockData
Medifast Inc logo

Medifast Inc (MED) stock

MEDNYSEMiscellaneous Food Preparations & Kindred ProductsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 26, 2026Score 10/3067% below fair value
$11.75−0.23 (-1.92%)

Close on Nov 20, 2026Market cap $131.40MP/E –Yield 0.00%

Medifast gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

Medifast's gross profit for the twelve months ending Sep 30, 2026 was $207.33M, down 33.4% year over year. For fiscal 2025 it was $275.19M, down 38.1% from the year before. Over ten years it grew 3.2% a year on average. The highest annual figure on record is $1.14B in fiscal 2022.

Annual gross profit

PeriodPeriod endValueChange
FY2025Dec 31, 2025$275.19M-38.1%
FY2024Dec 31, 2024$444.62M-42.7%
FY2023Dec 31, 2023$775.85M-32.0%
FY2022Dec 31, 2022$1.14B+1.1%
FY2021Dec 31, 2021$1.13B+61.6%
FY2020Dec 31, 2020$697.82M+30.0%
FY2019Dec 31, 2019$536.86M+41.3%
FY2018Dec 31, 2018$379.90M+66.8%
FY2017Dec 31, 2017$227.81M+10.8%
FY2016Dec 31, 2016$205.66M+2.2%
FY2015Dec 31, 2015$201.32M-3.8%
FY2014Dec 31, 2014$209.21M-13.0%
FY2013Dec 31, 2013$240.57M+2.0%
FY2012Dec 31, 2012$235.91M+5.1%
FY2011Dec 31, 2011$224.50M+16.6%
FY2010Dec 31, 2010$192.47M+54.7%
FY2009Dec 31, 2009$124.39M–

Quarterly gross profit

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$50.04M-19.5%
Q2 FY2026Jun 30, 2026$53.40M-30.3%
Q1 FY2026Mar 31, 2026$51.76M-38.6%
Q4 FY2025Dec 31, 2025$52.14M-40.9%
Q3 FY2025Sep 30, 2025$62.16M-41.2%
Q2 FY2025Jun 30, 2025$76.64M-37.9%
Q1 FY2025Mar 31, 2025$84.25M-33.8%
Q4 FY2024Dec 31, 2024$88.22M-37.6%
Q3 FY2024Sep 30, 2024$105.67M-40.4%
Q2 FY2024Jun 30, 2024$123.44M-41.4%
Q1 FY2024Mar 31, 2024$127.29M-48.3%
Q4 FY2023Dec 31, 2023$141.37M-39.5%
Q3 FY2023Sep 30, 2023$177.38M-37.3%
Q2 FY2023Jun 30, 2023$210.72M-34.5%
Q1 FY2023Mar 31, 2023$246.39M-18.5%
Q4 FY2022Dec 31, 2022$233.60M-16.1%
Q3 FY2022Sep 30, 2022$282.85M-7.9%
Q2 FY2022Jun 30, 2022$321.68M+9.5%
Q1 FY2022Mar 31, 2022$302.29M+21.6%
Q4 FY2021Dec 31, 2021$278.29M+39.7%
Q3 FY2021Sep 30, 2021$307.06M+50.5%
Q2 FY2021Jun 30, 2021$293.71M+84.4%
Q1 FY2021Mar 31, 2021$248.55M+83.8%
Q4 FY2020Dec 31, 2020$199.24M+55.6%
Q3 FY2020Sep 30, 2020$204.04M+42.7%
Q2 FY2020Jun 30, 2020$159.30M+13.2%
Q1 FY2020Mar 31, 2020$135.24M+8.1%
Q4 FY2019Dec 31, 2019$128.07M+17.4%
Q3 FY2019Sep 30, 2019$142.93M+33.3%
Q2 FY2019Jun 30, 2019$140.71M+58.5%
Q1 FY2019Mar 31, 2019$125.15M+67.3%
Q4 FY2018Dec 31, 2018$109.09M+84.5%
Q3 FY2018Sep 30, 2018$107.20M+84.2%
Q2 FY2018Jun 30, 2018$88.80M+54.1%
Q1 FY2018Mar 31, 2018$74.81M+41.4%
Q4 FY2017Dec 31, 2017$59.13M+25.6%
Q3 FY2017Sep 30, 2017$58.18M–
Q2 FY2017Jun 30, 2017$57.61M–
Q1 FY2017Mar 31, 2017$52.89M–
Q4 FY2016Dec 31, 2016$47.08M–

More Medifast figures

See a number that looks wrong?